Is Betahistine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 24 valid registrations of Betahistine, including BERTIGO 16 MG TABLET (16 mg, Tablet, SAR 28.40); BERTIGO 24 MG TABLET (24 mg, Tablet, SAR 30.05); BERTIGO 8 MG TABLET (8 mg, Tablet, SAR 16.80); BETAGEN (16 mg, Tablet, SAR 34.00); BETAGEN (8 mg, Tablet, SAR 40.70).

Active substance

Betahistine

SFDA 26
Health Canada 17
NHS prices 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
BERTIGO 16 MG TABLET	16 mg	Tablet · Oral use	30 Blister	SAR 28.40	Generic · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid
BERTIGO 24 MG TABLET	24 mg	Tablet · Oral use	30 Blister	SAR 30.05	Generic · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid
BERTIGO 8 MG TABLET	8 mg	Tablet · Oral use	30 Blister	SAR 16.80	Generic · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid
BETAGEN	16 mg	Tablet · Oral use	30 Blister	SAR 34.00	Generic · Prescription	RIYADH PHARMA	Valid
BETAGEN	8 mg	Tablet · Oral use	50 Blister	SAR 40.70	Generic · Prescription	RIYADH PHARMA	Valid
BETAGEN 24 mg tablet	24 mg	Tablet · Oral use	50 Blister	SAR 65.50	Generic · Prescription	RIYADH PHARMA	Valid
BETASERC 16MG TAB	16 mg	Tablet · Oral use	40 Blister	SAR 50.30	Generic · Prescription	Abbott Healthcare Products B.V	Valid
BETASERC 24 MG TABLETS	24 mg	Tablet · Oral use	50 Blister	SAR 77.05	Generic · Prescription	Abbott Healthcare Products B.V	Valid
BETASERC 8 MG TAB	8 mg	Tablet · Oral use	100 Blister	SAR 90.45	NCE · Prescription	Abbott Healthcare Products B.V	Valid
Betaquil	8 mg	Tablet · Oral use	30 Blister	SAR 13.60	Generic · Prescription	ALTAIF PHARMACEUTICALS COMPANY	Valid
Betaquil	16 mg	Tablet · Oral use	30 Blister	SAR 23.00	Generic · Prescription	ALTAIF PHARMACEUTICALS COMPANY	Valid
Betaquil	24 mg	Tablet · Oral use	30 Blister	SAR 24.30	Generic · Prescription	ALTAIF PHARMACEUTICALS COMPANY	Valid
Betaserc XL	48 mg	Film-coated tablet · Oral use	30 Blister	SAR 101.70	NCE · Prescription	Abbott Laboratories de Mexico S.A. de C.V	Valid
Betavert	8 mg	Tablet · Oral use	30 Blister	SAR 13.60	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Valid
Betavert	16 mg	Tablet · Oral use	30 Blister	SAR 23.00	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Valid
Betavert	24 mg	Tablet · Oral use	30 Blister	SAR 24.30	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Valid
LAVISTINA 16 mg tablet	16 mg	Tablet · Oral use	40 Blister	SAR 34.10	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
LAVISTINA 24 mg tablet	24 mg	Tablet · Oral use	50 Blister	SAR 45.05	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
LAVISTINA 8 mg tablet	8 mg	Tablet · Oral use	100 Blister	SAR 50.40	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
Verotec	8 mg	Tablet · Oral use	60 Blister	SAR 27.20	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
Verotec	16 mg	Tablet · Oral use	50 Blister	SAR 38.35	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
Verotec	24 mg	Tablet · Oral use	50 Blister	SAR 40.50	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
Verotec	8 mg	Tablet · Oral use	1500 Blister	SAR 570.10	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
Verotec	16 mg	Tablet · Oral use	900 Blister	SAR 530.70	Generic · Prescription	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
BETAGEN 24 mg tablet	24 mg	Tablet · Oral use	30 Blister	SAR 24.30	Generic · Prescription	RIYADH PHARMA	Withdrawn by MAH · Not Marketed

1 more — full table

Indications — CHI Daman Drug Formulary

VERTIGO - MENIERE'S DISEASE

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
AURO-BETAHISTINE	02449145	8 MG	TABLET · ORAL	AURO PHARMA INC
AURO-BETAHISTINE	02449153	16 MG	TABLET · ORAL	AURO PHARMA INC
AURO-BETAHISTINE	02449161	24 MG	TABLET · ORAL	AURO PHARMA INC
M-BETAHISTINE	02519682	8 MG	TABLET · ORAL	MANTRA PHARMA INC
M-BETAHISTINE	02519690	16 MG	TABLET · ORAL	MANTRA PHARMA INC
M-BETAHISTINE	02519704	24 MG	TABLET · ORAL	MANTRA PHARMA INC
MINT-BETAHISTINE	02538121	8 MG	TABLET · ORAL	MINT PHARMACEUTICALS INC
MINT-BETAHISTINE	02538148	16 MG	TABLET · ORAL	MINT PHARMACEUTICALS INC
MINT-BETAHISTINE	02538156	24 MG	TABLET · ORAL	MINT PHARMACEUTICALS INC
NRA-BETAHISTINE	02544911	8 MG	TABLET · ORAL	NORA PHARMA INC
NRA-BETAHISTINE	02544938	16 MG	TABLET · ORAL	NORA PHARMA INC
NRA-BETAHISTINE	02544946	24 MG	TABLET · ORAL	NORA PHARMA INC
SERC	02243878	16 MG	TABLET · ORAL	BGP PHARMA ULC
SERC	02247998	24 MG	TABLET · ORAL	BGP PHARMA ULC
TEVA-BETAHISTINE	02280183	8 MG	TABLET · ORAL	TEVA CANADA LIMITED
TEVA-BETAHISTINE	02280191	16 MG	TABLET · ORAL	TEVA CANADA LIMITED
TEVA-BETAHISTINE	02280205	24 MG	TABLET · ORAL	TEVA CANADA LIMITED

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Betahistine 16mg tablets	£1.62	84 tablet	1 Oct 2026
NHS Drug Tariff	Betahistine 24mg tablets	£8.00	84 tablet	1 Oct 2026
NHS Drug Tariff	Betahistine 8mg tablets	£1.26	84 tablet	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.